iCarbonX Secures Over $100 Million in Series A Funding Led by Tencent

On April 11, iCarbonX, founded by Wang Jun, former CEO of BGI Genomics, completed its Series A equity financing, raising over USD 100 million and achieving a post-money valuation of nearly USD 1 billion. Major investors in this round included internet giant Tencent, Zhongyuan Union Cell & Gene Engineering Corp., a leading player in the stem cell industry, and the well-capitalized Tianfu Group.

It is reported that Shenzhen iCarbonX Intelligent Technology Co., Ltd. was established on October 27, 2015. Its founder, Wang Jun, participated in the founding of BGI Genomics during his doctoral studies in 1999. He led three rounds of financing for BGI Tech, BGI Medical, and BGI Group, totaling approximately $1 billion, and guided BGI Group toward its initial public offering. At the time of iCarbonX’s establishment, Tencent CEO Ma Huateng,Yang Shuang, the current CEO of BGI Group, also attended the founding ceremony in person.



iCarbonX is building an ecosystem for digital life centered on consumers’ big biological data, the internet, and artificial intelligence. By bringing together top-tier biotechnology and AI teams, it creates a personal health steward. Leveraging the world’s most professional, exponentially growing, holographic, end-to-end healthcare big data, and employing cutting-edge data mining and machine analytics, iCarbonX delivers exclusive health index analysis and predictions for individuals.

iCarbonX’s founding team boasts an all-star lineup, primarily hailing from BGI Genomics, with extensive experience in omics technologies, mobile health, healthcare services, biological data analysis, artificial intelligence, and data mining.including Wu Chun, former Chief Operating Officer of BGI; Li Yingrui, Chief Scientist; Li Hao, Chief Information Officer; Yang Qiang, Chair of the International Joint Conference on Artificial Intelligence; Gu Zhenglong, Professor at the College of Human Ecology, Cornell University; and Ai Cheng, Founder of iAsk Media.

Before founding the company, Wang Jun shared this reflection in a keynote speech at Peking University: “Life data-based personalized health management powered by artificial intelligence gives genomic data its true meaning. Of course, genomic data alone is insufficient; it is merely one category of data. If we can aggregate all other types of data and apply such AI-driven methods to health management, this would represent the most significant application I can envision for the future bio-industry. This application is fundamentally data-driven and built on an open platform, evolving into a service-oriented e-commerce model within an open ecosystem. It will become a personalized health and medical management solution powered by data and driven by artificial intelligence. This is precisely what I aim to achieve through my current entrepreneurial venture.”